BIIB

ALLKA Research AMGN BIIB Biotechnology REGN RHHBY Uncategorized

Why Dupixent Keeps Regeneron A Top Big Pharma Pick

Feb 27, 2026

AZN BBIO BIIB Biotechnology Bret Jensen GSK IONS NTLA NVS PFE REGN Uncategorized

Ionis Pharmaceuticals: Digesting Recent Events

Feb 27, 2026

BIIB Biotechnology BRCTF ESAIY ESALF SUPN Uncategorized

Biogen projects 2026 revenue drop despite Q4 beat

Feb 6, 2026

BIIB Biotechnology Uncategorized

Biogen Q4 2025 Earnings Preview

Feb 5, 2026

BIIB Biotechnology Uncategorized

Biogen sees Q4 IPR&D impacts on EPS by ~$1.26/share

Jan 14, 2026

ABBV AZN BIIB Biotechnology GSK JNJ NVS RHHBY Uncategorized

AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma

Dec 10, 2025